1-4 of 4
Daniel Morgensztern, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence and Outcomes for Low Risk Myelodysplastic Syndrome: A Surveillance, Epidemiology and End Results (SEER) Study

Yue Zhang, MD, MPH, Nikolai A. Podoltsev, MD, PhD, Bonnie E. Gould Rothberg, MD, PhD, MPH, Madhav V. Dhodapkar, MD, Daniel Morgensztern, MD
Journal: Blood
Blood (2012) 120 (21): 4944.
https://doi.org/10.1182/blood.V120.21.4944.4944
Published: 2012
Journal Articles

High Remission Rates and Prolonged Progression Free Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma Treated with R-MACLOIVAM-T

Peter J Hosein, MD, Daniel Morgensztern, MD, Francine Coleman, MPH, Gail Walker, PhD, Maricer Escalon, MD, Joseph Rosenblatt, MD, Izidore S Lossos, MD
Journal: Blood
Blood (2008) 112 (11): 3597.
https://doi.org/10.1182/blood.V112.11.3597.3597
Published: 2008
Journal Articles

Lack of Survival Improvement in Patients with Large Cell Lymphomas of T-Cell Phenotype: A SEER Analysis Comparing Outcomes According to Phenotype and Year of Diagnosis.

Daniel Morgensztern, MD, Gail Walker, PhD., Leonidas Koniaris, M.D., Izidore S. Lossos, M.D.
Journal: Blood
Blood (2007) 110 (11): 3577.
https://doi.org/10.1182/blood.V110.11.3577.3577
Published: 2007
Journal Articles

Phase-2 Study of R-MACLO-IVAM-T in Newly Diagnosed Mantle Cell Lymphoma.

Izidore S. Lossos, MD, Francine Colleman, Gail Walker, Maricer Escalon, MD, Joseph Rosenblatt, MD, Daniel Morgensztern, MD
Journal: Blood
Blood (2007) 110 (11): 1363.
https://doi.org/10.1182/blood.V110.11.1363.1363
Published: 2007